GENELINK INC (GNLK)

0.00
0.00 (0.00)
OTC
Prev Close 0.00
Open 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.02
Volume 150.00K
Exchange OTC
Shares Outstanding 265.02M
Market Cap 424.00K
Div & Yield N.A. (N.A)

GeneLink Anticipates Completion Of Audit

Trading Symbol Change Expected To Be Temporary

Shareholder Update Regarding Capsalus Revenue Reporting Delay On Fiscal 2011 10-K Annual Report

Capsalus Corp. (OTCBB: WELL and, temporarily, OTCBB: WELLE), today announced that the necessary revenue numbers for its fourth quarter are not yet available to include in its Fiscal 2011 10-K annual report for the ...

Capsalus Corp. Completes Purchase Of GeneWize Life Sciences, Inc.

Capsalus Corp. ( OTCBB:WELL) has completed the acquisition of the stock of GeneWize Life Sciences, Inc.

GeneLink Marketing Efforts Poised To Show Results

Company Reports Third Quarter Financial Results

GeneLink BioSciences, Inc. Ranked Number 33 Fastest Growing Company In North America On Deloitte's 2011 Technology Fast 500™

Attributes its 4,363 Percent Revenue Growth to its Leadership Position in Consumer Genetics

GeneLink Biosciences Agrees To Sell GeneWize Life Sciences

GeneLink Biosciences, Inc. ( OTCBB:GNLK), a leading consumer genomics biotech company, has finalized a definitive agreement with Capsalus Corp.

Capsalus Corp. Announces Agreement To Buy GeneWize Life Sciences, Inc.

Capsalus Corp. ( OTCBB:WELL), a public company operating in the health and wellness space, has finalized the definitive agreement with leading biosciences company GeneLink Biosciences, Inc.

GeneWize Expands DNA Customization Into 3 Mega Markets

DNA Inspired Nutrition, Weight, & Skin Care Promise New Appeal from Large Consumer Base

GeneLink Announces New Licensing Partner

Robert B. Trussell to Market GeneLink's Consumer Genetics Products

Gary J. Beeman Appointed CEO Of GeneLink BioSciences, Inc.

Sharon M. Tahaney Appointed President of GeneWize Life Sciences, Inc.